BACKGROUND: Although cancer survivors are more likely to be unemployed than individuals without a cancer history, employment participation after treatment of early-stage breast cancer has not been widely studied to date. The objectives of the current study were to evaluate employment trajectories in a cohort of patients with early-stage breast cancer and age-matched controls from the time of diagnosis to the 2-year follow-up, and identify factors associated with diminished and emerging employment participation. METHODS: As part of a larger cohort study of 1096 patients with early-stage breast cancer and same-aged women without breast cancer, data from 723 working-age (aged 40-64 years) women (347 patients and 376 controls) were analyzed to evaluate 4 employment trajectories (sustained unemployment, diminished employment, emerging employment, and sustained employment). Multivariable logistic regression models were used to identify factors associated with diminished employment versus sustained employment, and emerging employment versus sustained unemployment. RESULTS: Lower percentages of patients (71%) compared with controls (79%) reported full-time or part-time employment at enrollment (P<.01). Fatigue was a significant predictor of diminished employment for both patients (odds ratio [OR], 5.71; 95% confidence interval [95% CI], 2.48-13.15) and controls (OR, 2.38; 95% CI, 1.21-4.68). Among patients, African American race (OR, 4.02; 95% CI, 1.57-10.28) and public/uninsured insurance status (OR, 4.76; 95% CI, 1.34-12.38) were found to be associated with diminished employment. Among controls, high social support was associated with emerging employment (OR, 3.12; 95% CI,. CONCLUSIONS: Fatigued patients, African American patients, and publicly insured/uninsured patients with cancer were more likely to experience diminished employment after 2 years of follow-up. Further investigation with longer follow-up is warranted to identify factors associated with these disparities in employment participation after treatment of early-stage breast cancer. Cancer 2018;124:2026-35.
INTRODUCTION
Breast cancer is the most frequently diagnosed cancer among women in the United States, excluding skin cancer. 1 Advances in detection and treatment over the last few decades have led to increases in survival rates and life expectancy. 1 Greater than 3 million women in the United States are living with breast cancer, and by 2024, the number of women with breast cancer is expected to rise to 4 million. 2 As the population of breast cancer survivors continues to increase, it is increasingly important to address the unique needs of this growing population, including long-term health care and the return to normalcy.
Compared with other female cancers, breast cancer is more frequently diagnosed among women of working age (aged <65 years). 1 As a result, the impact of breast cancer on employment outcomes has the potential to be substantial. During treatment, work schedule changes to accommodate provider visits and the reduced physical or mental ability to perform occupational tasks may result in a premature exit from the workforce. Furthermore, the presence of lingering side effects after surgical or adjuvant therapy may influence employment outcomes long after treatment ends. 3, 4 Although cancer survivors are more likely to report unemployment than individuals without a cancer history, [5] [6] [7] [8] [9] [10] working after diagnosis may represent a return to normalcy for some patients with breast cancer. In addition to the added benefit of employersponsored health insurance, paid employment has the potential to mitigate the financial stresses associated with cancer. 11, 12 Moreover, for women with breast cancer, employment could play a significant role in postdiagnostic health. Health benefits associated with employment include an increased sense of purpose, higher self-esteem, and a stronger sense of social support from others, all of which have been associated with improved quality of life.
To the best of our knowledge, only a limited number of longitudinal studies have examined employment outcomes among women diagnosed with breast cancer. [15] [16] [17] Sociodemographic factors such as older age, lower educational level, and lower income 18, 19 ; treatment-related factors such as axillary lymph node dissection, chemotherapy, and mastectomy 6 ; and psychosocial factors such as poor self-rated health and social support have been associated with poorer employment outcomes. 20, 21 The objectives of the current study were to: 1) evaluate 2-year employment participation trajectories at 2 years of followup in a cohort of patients after the diagnosis of early-stage breast cancer and an age-matched control group without a breast cancer history; and 2) identify sociodemographic, psychosocial, and clinical factors associated with diminished and emerging employment in this cohort.
MATERIALS AND METHODS

Participants
We examined data from a longitudinal prospective cohort study of women diagnosed with incident (AJCC TNM staging system) stage 0 to stage IIA breast cancer and women without any breast cancer history (controls). The purpose of the parent study was to examine changes in quality of life over time in women diagnosed with early-stage breast cancer and age-matched controls. 22 Descriptions of the study population have been published elsewhere. [22] [23] [24] [25] Briefly, between 2003 and 2007, women aged 40 years were recruited from 2 sites in St. Louis, Missouri: Siteman Cancer Center at BarnesJewish Hospital/Washington University School of Medicine and Saint Louis University School of Medicine. Women with a diagnosis of first primary breast cancer were eligible for the study, and controls were identified within 2 weeks of a normal/benign screening mammogram and were frequency-matched by age group to patients. Women aged 40 years were included in the study because screening mammography was recommended for women in this age group during the study period. 26 Exclusion criteria included a prior history of in situ or invasive breast cancer, receipt of neoadjuvant chemotherapy, inability to speak and understand English, or evidence of cognitive impairment on the OrientationMemory-Concentration Test (administered to participants aged 65 years). 27 Computer-assisted telephone interviews were administered to study participants at 4 times: at 4 to 6 weeks, 6 months, 1 year, and 2 years after definitive surgical treatment (patients) or screening mammogram (controls). The study was reviewed and approved by the institution review boards at both institutions, and informed consent was obtained from all study participants.
A total of 1096 women (549 patients and 547 controls) were enrolled in the study, including 826 participants who were of working age (aged <65 years) at the time of enrollment. 22 For this exploratory, secondary data analysis of employment participation trajectories, we excluded women who reported being retired at the time of enrollment (96 women). We also limited our analysis to white and African American women because of the small percentage of participants from other racial/ethnic groups (7 women). Therefore, the current study included a total of 723 study participants (347 patients and 376 controls).
Employment Outcomes
We evaluated employment trajectories at 2 years of follow-up. At each interview, study participants were asked whether they were currently "employed full-time," "employed part-time," "unemployed/unable to work," "homemaker," or "retired." Participants who reported full-time or part-time work were classified at employed. We created 4 categories to classify the employment trajectories of study participants: 1) sustained employment (employed at each time point); 2) diminished employment (employed at time 1 but not at any of the other time points); 3) emerging employment (unemployed/unable to work/homemaker at time 1 and employed at time 4 ); and 4) sustained unemployment (unemployed/unable to work/homemaker at each time point). The primary outcome measures of this study were diminished employment and emerging employment at the 2-year follow-up.
Sociodemographic, Psychosocial, and Patient Characteristics
Interviews included questions regarding participants' age, race/ethnicity, marital status, income, educational level, and insurance status. Comorbidity was determined based on the Charlson Comorbidity Index. 28, 29 At each interview, quality of life was measured using the 8 subscales of the RAND 36-Item Health Survey (RAND-36). [30] [31] [32] We used the vitality subscale of the RAND-36 to measure participants' fatigue. This subscale is comprised of 4 items asking how patients felt "during the past 4 weeks." Standardized scores range from 0 to 100, with higher scores indicating greater vitality (ie, lower scores reflect more fatigue). We used 2 questions to determine depression history at the time of enrollment: "Has a physician ever told you that you had depression?" and "Have you ever been treated for depression with medication or psychotherapy?" An affirmative response to either question indicated a history of depression. The 19-item Medical Outcomes Study Social Support Survey was used to assess social support, in which a score of 1 indicates "none of the time" and a score of 5 indicates "all the time"; higher scores indicate more social support. 33 All patients underwent surgery (lumpectomy or mastectomy), and medical record review confirmed patients' receipt of radiotherapy (RT), chemotherapy, or endocrine therapy (which is prescribed for patients with estrogen receptor-positive tumors) during follow-up.
Statistical Analysis
Descriptive statistics were used to characterize the distribution of sociodemographic, psychosocial, and patient characteristics by diagnostic group (patients vs controls). We performed chi-square analyses and analysis of variance to examine differences between diagnostic groups by sociodemographic and psychosocial characteristics. Chisquare tests and analyses of variance also were conducted to examine sociodemographic, psychosocial, and patient (receipt of RT, chemotherapy, and endocrine therapy) characteristics in association with the trajectory of employment.
We used 2 multivariable logistic regression models to estimate adjusted odds ratios (ORs) and 95% confidence intervals for characteristics associated with employment trajectory at the 2-year follow-up. In the first model, we evaluated the associations between participant characteristics and diminished employment (vs sustained employment). In the second model, we evaluated the associations between participant characteristics and emerging employment (vs sustained unemployment). Potential model covariates, based on the literature, 17,34-38 included age (continuous), race (African American or white), marital status (married/partnered or not married/partnered), socioeconomic status (income <$50,000 and high school education, income <$50,000 and >high school education, or income $50,000), insurance type (public/ uninsured/unknown or private), number of comorbidities (2, 1, or none), social support (continuous), vitality (median split of RAND-36 vitality subscale), history of depression (yes or no), treatment during study (among patients only: surgery only; surgery and chemotherapy; surgery and RT; and surgery, chemotherapy, and RT), and endocrine therapy during study (among patients only: yes or no). Adjusted ORs were estimated separately for the patient and control groups. All statistical analyses were conducted using SAS statistical software (version 9.1; SAS Institute Inc, Cary, North Carolina).
RESULTS
Characteristics of the Study Sample
The study sample included a total of 347 patients and 376 controls. Descriptive characteristics of the sample by diagnosis group are reported in Table 1 . The average age at baseline for both diagnostic groups was 52 years (median, 52 years; range, 40-64 years). Lower percentages of patients than controls had private insurance and reported full-time or part-time employment at enrollment. A significant difference in socioeconomic status was observed between the groups, with a greater percentage of controls reporting an annual household income of $50,000 compared with patients. A higher percentage of patients scored below the median of the RAND-36 vitality subscale compared with controls, and the mean social support score for patients was significantly higher than that for controls. We found no significant differences in any of the other baseline characteristics between the patient and control groups (Table 1) . Only 5 patients experienced a recurrence of their breast cancer during follow-up. Table 2 and Figure 1 show the characteristics of the employment participation trajectories of the study sample by diagnostic group. The percentage of women with sustained employment participation after 2 years was 56% in the patient group and 63% in the control group. There were no significant differences in employment trajectories noted between the 2 diagnostic groups ( Table 2) .
Univariate characteristics of the women who were employed at the time of enrollment are presented in Table  3 . Of the 245 patients who were employed at enrollment, 50 (20%) experienced diminished employment during follow-up. Among patients, diminished employment participation was more likely to occur for women who were African American; had public, uninsured, or unknown insurance status; and a reported vitality score below the median. A total of 59 of 297 controls (20%) experienced diminished employment. Similar to patients, African American race and a vitality score below the median were associated with diminished employment. However, in contrast to the patient group, low socioeconomic status also was found to be associated with diminished employment among controls.
In Table 4 , we summarize the univariate characteristics of women who were not employed at the time of enrollment. Approximately 49% of patients (50 of 102 patients) and 42% of controls (33 of 79 controls) experienced new employment during follow-up. Surgical patients who were treated with both chemotherapy and RT and surgical patients treated with chemotherapy only were more likely to experience new employment compared with patients treated with surgery alone. Patients treated with endocrine therapy were less likely to experience new employment. Among controls, higher socioeconomic status, private insurance status, the absence of comorbidities, age, and social support were associated with new employment. Table 5 presents adjusted ORs and 95% confidence intervals for diminished employment at the 2-year follow-up. African American race and public or uninsured insurance status were found to be significantly associated with diminished employment participation among patients, after adjusting for age, marital status, socioeconomic status, vitality score, comorbidity, social support, treatment type, and receipt of endocrine therapy during the study (Table 5 ). In both patients and controls, we observed a significant increase in the risk of diminished employment among women who scored below the median on the vitality subscale. Only 1 of the 5 patients with disease recurrence reported diminished employment.
Diminished Employment Participation
Emerging Employment Participation
We observed a greater likelihood of emerging employment participation in controls who reported higher levels of social support. We did not observe any significant associations with emerging employment among patients (Table 6 ), and 4 of the patients with disease recurrence reported sustained unemployment at follow-up.
DISCUSSION
In the current study of patients with early-stage breast cancer and age-matched controls, we observed that African American patients were 4 times more likely to experience diminished employment participation during the 2 years after definitive surgical treatment compared with white patients. We also observed that insurance status was associated with diminished employment: patients with public, uninsured, or unknown insurance status were 4.7 times more likely to experience diminished employment participation compared with patients with private insurance. In both patients and controls, fatigue was associated with diminished employment, although the association among controls was of lower magnitude than that of patients. The current study focused on patients with earlystage breast cancer, a population that has an excellent prognosis for disease-free survival. 39 Although the current study sample included patients with stages 0 to II breast cancer, only 5 patients experienced a disease recurrence over the 2 years of follow-up, and we did not find any significant associations between employment participation outcomes and adjuvant therapies such as chemotherapy, RT, and hormonal therapy. However, fatigue was found to be a significant predictor of diminished employment participation in both patient and control groups. Cancer- Original Article related fatigue is among the most common and debilitating symptoms in patients with breast cancer. With significant impacts that can last long after treatment, the results of the current study support prior findings that fatigue can be a barrier to both continued employment and a return to work after cancer treatment. 21, 35, [40] [41] [42] [43] [44] The findings of the current study that African American race was independently associated with diminished employment participation are consistent with 2 prior US longitudinal investigations of the relationship between race/ethnicity and employment after breast cancer. In these studies, which included employed, insured women with newly diagnosed breast cancer, African American patients were less likely than white patients to return to work at 9 months, 14 and at 18 months after chemotherapy, RT, or surgical treatment. 34 In the current study, neither surgery alone nor surgery combined with adjuvant therapies was associated with employment participation 
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Cancer May 1, 2018 outcomes in the multivariable analyses. Nonetheless, the current study findings that sociodemographic factors (race and insurance status), but not type of treatment received, were associated with diminished employment participation are in contrast to some, but not all, studies that have evaluated associations between treatment and employment outcomes among survivors of breast cancer. 17, 35, 37, 38, [45] [46] [47] [48] [49] [50] [51] A strength of the current study is that we examined employment patterns among women who were unemployed at the time of enrollment. With regard to emerging employment participation in patients, we did not observe any significant associations with any sociodemographic, psychosocial, or clinical factors. In contrast, among controls, we observed a greater likelihood of emerging employment participation among women who reported higher levels of social support. The physical burden of cancer may affect patients' employment-seeking behaviors. Furthermore, social support, although necessary, may not be sufficient to overcome functional limitations in patients who would like to work, whereas controls may not have these same functional limitations, and those controls with support may be better enabled to seek employment over time. However, given the relatively small sample sizes of the sustained unemployment referent groups (22 participants in the patient group and 18 participants in the control group), associations should be interpreted with caution. Nevertheless, previous research has indicated a role for psychosocial factors in long-term employment outcomes after cancer treatment. 43, 52, 53 Additional strengths of the current study include its longitudinal design and the inclusion of a control group of age-matched women. The use of a control group allowed us to account for contextual factors, such as social and economic conditions, that may have had an influence on employment participation during the study period. The current study also has several limitations. First, this study was an exploratory, secondary analysis of existing data, and we were underpowered to detect differences between groups in adjusted models (eg, patients with emerging employment vs sustained unemployment). In addition, there were differences in the baseline characteristics between patients and controls, including differences in employment status and fatigue at the time of enrollment; there also may be differences in unmeasured variables. The current study sample included women aged 40 years, and results may not be generalizable to younger patients with breast cancer. Although we collected information regarding a participant's inability to work, participants were not asked why they were unable to work. Our questionnaire captured critical information regarding socioeconomic factors, psychosocial factors such as social support, and clinical factors such as adjuvant therapies. However, we did not assess participants' intentions to continue or discontinue employment during follow-up. We also did not collect information regarding employment status before breast cancer diagnosis and thus were unable to provide insight concerning how prediagnosis patterns correlated with postdiagnosis patterns. We combined full-time and part-time employment without differentiation, and although part-time workers may have been more likely to continue or resume employment than full-time workers, the small sample of part-time workers (14%) herein prohibited us from investigating potential differences between full-time and part-time employment. Finally, we lacked detailed information regarding the type of employment (eg, professional occupations vs service occupations) that would allow us to assess whether employment after treatment was influenced by contextual factors such as job autonomy, schedule flexibility, physically demanding tasks, and organizational policies. These modifiable workplace factors could influence employment outcomes among patients with early-stage breast cancer and should be considered in future studies.
Conclusions
The results of the current study indicate that fatigue, African American race, and nonprivate insurance status were associated with diminished employment participation among patients with early-stage breast cancer 2 years after surgical treatment. Future studies should examine facilitators and barriers to employment participation after breast cancer treatment, particularly among vulnerable subgroups. Moreover, because employment in the United States is associated with income and access to high-quality health care, research that investigates the relationships between employment participation and health-related outcomes (quality of life and adherence to treatment and screening guidelines) among patients with breast cancer is needed. Patients with early-stage breast cancer have a more favorable prognosis than those with late-stage disease, and future examinations into employment participation outcomes after treatment will be important for early-stage breast cancer research in the United States as the number of survivors increases in the coming decades.
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